AKT1 and glioblastoma: Additionally, the EGFR/AKT pathway activates the mevalonate pathway, increasing cholesterol and other isoprenoid synthesis, providing metabolic flexibility for GBM cells to adapt to neighboring microenvironments and sustain their invasive capabilities [80,83].